chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccines went into 2-8 C thawstate on or about 24-Dec-2021; Received vaccine past its 30-days expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days expiry date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thawstate on or about 24-Dec-2021) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     Acute illness at the time of vaccination and up to one month before was reported as unknown. Chronic or long-standing health conditions was reported as unknown.     On 25-Jan-2022 at 4:31 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 25-Jan-2022 at 4:31 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thawstate on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days expiry date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thawstate on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient ethnicity was reported.  Prescriptions, over the counter medications, dietary supplements or herbal remedies being taken at time of vaccination or at the time of the adverse event were reported as unknown. Other vaccines given on the same day as Moderna COVID-19 vaccine and other vaccines received within one month prior to any dose of Moderna COVID-19 vaccine were reported as unknown.  No concomitant medications were provided by reporter.  No treatment medications were provided by reporter.  On 25-Jan-2022 at 16:31:52, patient received an expired booster dose.   This case was linked to MOD-2022-542869 (Patient Link).
pt devel fever & swelling down the arm;pt instructed to take APAP & return to clinic if problem persist;
The day after I got the vaccine, I had a lot of pain in my body and a temperature of 102.  That lasted for 4 days.  Temp when to 104.  Three weeks later I was getting a pacemaker.   I never had any heart issues before.  My pulse was always on the high end not the lower end   I don't know if this is an adverse event but it all has been very confusing
L deltoid swollen and red. Per mom, she noted just this PM, 5/11/06 at 16:00 PM, L deltoid hot to touch. Pt denies pain. No fever. MD notified and seen pt. Advised mom to apply ice compresses and give Motrin an needed.
Arm was sore for 2 days then resolved. Was fine for 3 weeks then dev soreness again in same location, swollen, red, very tender. Pain radiates into neck. Started on KEFLEX no improvement. Sent to ER and given IV ABS and changed to clindamycin.
doesn't feel that great; What she is feeling right now is similar to how she felt with covid.; This spontaneous case was reported by a health care professional and describes the occurrence of MALAISE (doesn't feel that great) and FEELING ABNORMAL (What she is feeling right now is similar to how she felt with covid.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.   On 23-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (doesn't feel that great) and FEELING ABNORMAL (What she is feeling right now is similar to how she felt with covid.). At the time of the report, MALAISE (doesn't feel that great) and FEELING ABNORMAL (What she is feeling right now is similar to how she felt with covid.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable No concomitant medications were reported No treatment drugs were reported
BREATHING DIFFICULTIES; CONSTANT COUGH; LUMP IN THE THROAT; FEEL LIKE HE IS DYING; SWALLOWING DIFFICULTY; AIRWAY BLOCKAGE; This spontaneous report received from a patient concerned a 54 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018 expiry: 25-MAY-2021) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced breathing difficulties. On 01-APR-2021, the subject experienced constant cough. On 01-APR-2021, the subject experienced lump in the throat. On 01-APR-2021, the subject experienced feel like he is dying. On 01-APR-2021, the subject experienced swallowing difficulty. On 01-APR-2021, the subject experienced airway blockage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the breathing difficulties, constant cough, lump in the throat, feel like he is dying, swallowing difficulty and airway blockage was not reported. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard procedure as case assessed as non serious.
About 12 hours after the shot, I got chills and really bad body ache.  The next morning, I had a fast heart rate.  Then I got a fever of 100.5.  I went to the doctor.  They did a Covid-19 test, positive results.
(L) arm bruised at injection site, showed up at 2 days. Soreness since shot. 3-4 inch wide red ring around almost entire arm about 4 inches from site of injection. Noticed redness on 6/25, saw MD and advised will go away, no raised patches or rash, no fever.
I started getting a body aches, a headache and chills around 6 p.m. the night that I got the vaccine. I ended up having a 102 degree fever later in the night with continued body aches, nausea, headache and chills. The morning after I got the vaccine I woke up feeling disoriented and nauseous. I had several spells of dry heaving that morning and a headache and body aches most of the day . I had soreness at the injection site for about a week.
This spontaneous report was received from a nurse, referring to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not provided. On unknown dates, multiple unspecified patients were vaccinated with improperly stored PROQUAD (lot# N012616 with expiration date 18-OCT-2018 or lot# N008826 with expiration date 12-SEP-2018 or lot# N004631 with expiration date 07-AUG-2018; concentration, dose, frequency and route were unknown) for prophylaxis; all reconstituted with properly stored sterile diluent (MRK) (lot# M047663 with expiration date 28-JUL-2019). The vaccines were stored at 6 to 14 degrees Fahrenheit for 45 minutes and the data logger was involved. There was no previous temperature excursion. No adverse effects were reported. No product quality complaint (PQC) was involved in this case. This is one of two reports received from the same reporter. Lot number N012616 has been verified to be a valid lot number for PROQUAD. Sender's Comments: US-009507513-1708USA010302.
Patient was vaccinated for COVID-19 on 1/21/21 and 2/11/21, so was fully vaccinated when testing positive for COVID-19 on 10/12/21.
RASH AROUND INJECTION SITE AND WHERE BAND-AID WAS APPLIED, HEADACHE, ACHING JOINTS
pt recvd vax 12noon 25SEP; fussy x 15' then quieted down; 1 hr later became febrile & fussy; seen @ hosp where WBC inc to 17.5; recvd Rocephin 500mg IM; now well 26SEP95
had low grade fever for about 1 d, but had high pitched scream x 3-4d; would cry so hard fell asleep for 1-1 1/2 hrs but if moved would wake & scream again;
This spontaneous report as received from a licensed nurse practitioner refers to a patient of unknown age. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot # not reported). ZOSTAVAX was exposed to temperature up to 24F for 67 days (1608 hours) and it was determined not viable. Improperly stored ZOSTAVAX had been administered to the patient. No adverse effects reported. This is one of several reports received from the same source (same reporter link: 1303USA011844 and 1304USA002221). Additional information has been requested.
pt brought to ED with SOB and cough; positive test in ED for COVID; O2 supplementation; remdesivir, Solu-Medrol, ABX; decrease in respiratory failure; code blue called, pt intubated; vasopressors needed to maintain BP; decrease in renal function; family chose to withdraw care and transition to comfort care; extubated and he passed away in the hospital
pt recvd vax & stated "can't see"; dizzy, sick to stomach & headache; sxs cleared up w/in 35-40 min xcept h/a;
L arm was swollen, very swollen x 5 days. Pt got better after the 5th day.
Employee phoned and reported what he believes is a symptom from the COVID-19 Vaccine. He reported almost like a fluttery, burst of energy feeling. He said his pulse was a little elevated  for him in the 80s, but regular. He stated he felt this way for about 1 hour, and then went away. It felt like he had just chugged 3 red bull drinks. He also said his arm he received the vaccination in was very sore the next day...more so than when getting the flu vaccination. This employee is an ED physician.
Information has been received from a pharmacist concerning a patient who was vaccinated with MMR II. It was reported that the patient was given MMR II in the past as a child and had low mumps titers. No product quality complaint was involved. No other information was reported. No further information is available.
Pt complains of soreness at injection site that evening and next day. Soreness went away after 2 days. A few weeks later, pt developed pain ache in shoulder, elbow, and outer left hip area. Pain in elbow, hip and shoulder lasted 10 days. There was still pain in the upper left bicep area.
Redness, skin warm/hot to touch, tenderness/ache in arm, limited range of motion, swelling, hardening of arm. Pt tried heat/ice, ALEVE, TYLENOL, since symptoms began in the afternoon of 07/06, the outcome was no change in status.
Ischemic stroke 2/24/2021 (2 days Post second Moderna administration)
A nurse reported that a 12 month old male, post vax, on 10/3/01, developed a fever of 101F-102F, as well as fussiness. On 10/4/01, the child's temperature was 103F and the fussiness persisted. On 10/5/01, the fussiness continued and the child's mother treated him with acetaminophen. Subsequently, the child was "cool to touch". He later experienced a seizure and was transported to a hospital, where his temperature was 104F. He was hospitalized for 24 hour observation. Unspecified lab tests were performed and the reporter indicated that "something was detected in the blood culture". The child was treated with unspecified antibiotics. No further information was available at the date of this report.
About 2-3 days following the vaccine I realized I was not very hungry and the foods I did eat did not have the same taste, as in just off flavor. Also had no desire to eat anything sweet. I was curious the changes so looked back on calendar and realized I had the 2nd vaccine shot on Apr 9 and wondered if that altered my appetite and flavor for food. I weighed 228 lbs at that time and started tracking the weight loss. So far (May 26 2021)  have lost 14 pounds. I do not eat snacks at all between or after meals any more - just eat my 3 meals a day, but the quantity is less. The flavor of food is coming back however, but have not had the desire for sweets.  No other adverse indications; I feel absolutely fine. Just thought it strange and coincidental that suddenly I stopped desiring sweets and appetite changed. I talked with my doctor at appointment with him on May 24 and he suggested I fill out this report.  As I look at question #20 if patient has recovered - I will check "Unknown" just because I'm not sure how much current eating lifestyle is due now to whatever caused it to begin with or now 42 days later this is just habit for me. Also question #21 - I did not seek dr appoint because of the appetite change, that May 24 appt was scheduled before I had the shot. Just figured I'd mention it to him as long as I was there.
Patient is post menopausal and has not experienced vaginal bleeding for years. She experienced vaginal bleeding beginning about 9 days after being vaccinated.
This spontaneous report as received from an unspecified reporter (Control #54417) concerning a 70 year old female patient. Medical history and concurrent conditions were not reported. Patient had no known allergies. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (dose and route were not reported) Lot # J011651; Expiration date: 22-AUG-2015 (reported as 31-AUG-2014). In 2014, the patient had swelling of the arm, body aches, weak and fever. Patient did not had any trouble breathing and have no known allergies. Once patient was put on antibiotics, patient got better. The outcome of the events was reported as recovering. This is one of 4 reports from the same reporter (1403USA002056, 1403USA007924 and 1403USA007926). Additional information has been requested.
Headache, Myalgia, Fever, lethargy, chills, pain injection site Narrative:
tightness in her chest and some mild wheezing as well as a funny sensation in her throat gave benadryl 25 mg and methyprednisolone 125 mg IV one time symptoms improved after medications given
Patient is pregnant, currently 13weeks.  At the time of the vaccination, she was 5w5d EGA.
7/24/21: patient test positive on Tuesday. yesterday became confused. room O2 sats at 88. Patient received COVID-19 Pfizer vaccine on 2/12/2021 and 3/5/2021.  Diagnosed with metabolic encephalopathy probably due to COVID-19 infection and dehydration. SIRS/Sepsis, acute respiratory failure with hypoxia, COVID-19 pneumonia. patient discharged on 7/29/21
flu; Initial information received on 18-Feb-2021 regarding an unsolicited valid non-serious case received from a consumer or non-health care professional.  This case involves a patient (unknown age and gender) who experienced flu (influenza), after the patient received INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor and the patient's past medical treatment(s), vaccination(s), family history and concomitant medication were not reported.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious flu (influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  It was reported that it was just not as bad. It was unknown if the patient experienced any additional symptoms/events. Medication details and reason for taking the medicine: Not reported  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available on batch number for this case.
painful and hurts a lot; got a 102.6 Fahrenheit degrees fever after receiving their first dose of the Moderna covid19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (painful and hurts a lot) and PYREXIA (got a 102.6 Fahrenheit degrees fever after receiving their first dose of the Moderna covid19 vaccine) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017ez1a) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Aug-2021, the patient experienced PYREXIA (got a 102.6 Fahrenheit degrees fever after receiving their first dose of the Moderna covid19 vaccine). On an unknown date, the patient experienced VACCINATION SITE PAIN (painful and hurts a lot). At the time of the report, VACCINATION SITE PAIN (painful and hurts a lot) and PYREXIA (got a 102.6 Fahrenheit degrees fever after receiving their first dose of the Moderna covid19 vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Aug-2021, Body temperature: 102.6 (High) 102.6 Fahrenheit degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.    Reporter did not allow further contact
Lump in throat feeling immediately, dispersed within an hour. Dizziness 24/7, immediate, ongoing as of 7 days later. Frequent heart palpitations, immediate, ongoing as of 7 days later. Worsening tachycardia, immediate, ongoing as of 7 days later. Severe sinus congestion, within 2 hours, ongoing as of 7 days later. General feeling of malaise, immediate, ongoing as of 7 days later. Pain in right arm around injection site, within a few hours, dispersed within 4 days Significant circadian rhythm disruption,  ongoing as of 7 days later.
taken home from school the next day due to fever of 103; pt c/o nausea & dizziness; pts mom called family physician & advised to give plenty of fluids for fever;
Anxious feeling Heart racing  Feeling hot  BP 157/103, HR 114. Snack and juice given. BP repeated 161/94, HR 71.  Reported feeling better and okay to leave.  Went home.
Arm swelling at shot location, heavy feeling in shot arm, moderate headache, mild shortness of breath, sore throat.
Adverse Event: Guest had complaints of shakiness, Nausea, "Out of body experience".  Treatment: Guest assisted to the floor, then transferred to medical area, provided two apple juices - reported he had not eaten and he experienced the above adverse event after he saw blood from his injection site. Outcomes: Guests reports feeling better after after 15 minutes and above interventions. Left facility with his mother via POV.
Initial information received on 18-Jul-2018 regarding an unsolicited valid non-serious case received from healthcare professional. This case involves a 12 months old female patient who had administered to infant at 12 months which is early in the series, while she received vaccine IMOVAX POLIO. The patients past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included ACTHIB for Immunisation; MMR for Immunisation; VARICELLA VACC. for Immunisation; and HEPATITIS A for Immunisation. On 16-Jul-2018, the patient received a dose of suspect 0.5 ml IMOVAX POLIO lot N1K92M (frequency once) via intramuscular route in the left thigh. It was an actual medication error due to inappropriate schedule of vaccine administered. It was reported that vaccine was administered to infant at 12 months which is early in the series. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Hospitalized (11.30.21);  COVID-19 positive (11.30.21);  fully vaccinated  patient is pregnant  ESTIMATED DUE DATE: Estimated Date of Delivery: 4/7/22 GESTATIONAL AGE AT DELIVERY: 22w4d  G6P2032 Admission Date: 11/30/2021 Discharge Date: 12/6/2021  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM:  Severe persistent asthma with exacerbation [J45.51] 22 weeks gestation of pregnancy [Z3A.22] COVID-19 virus infection [U07.1] Acute asthma exacerbation [J45.901] COVID-19 affecting pregnancy, antepartum [O98.519, U07.1] Chief Complaint: Shortness of breath, cough   ASSESSMENT / PLAN: Patient is a 36 y.o. female G6P2032 at 21w5d who presents with shortness of breath thought to be secondary to asthma exacerbation and COVID 19 infection in pregnancy. Severe persistent asthma with acute exacerbation - Presenting with 3 days of shortness of breath and cough; noted to have conversational dyspnea on presentation to the ED  - CXR unremarkable - Saturating 99-100% on room air  - As below, new diagnosis of COVID on admission  - Asthma controlled with symbicort, spivira, singulair, and prn albuterol at home; increased albuterol use at home, 3-4 times additional use per day  - Given DuoNeb, albuterol neb, IV solumedrol, and IV magnesium sulfate in the ED with some improvement in her symptoms  - Follows with pulmonology as outpatient - Last admitted in July of this year with asthma exacerbation and parainfleunza virus; required IV steroids and PO prednisone taper  Plan: - Admit to 4C for further monitoring of respiratory status - Continuous pulse ox  - Continue DuoNebs every four hours, sooner if needed; continue home inhalers - Pulmonology consulted, appreciate assistance  COVID-19 in pregnancy  - Endorses symptoms since 11/28 (day 3 of symptoms), +COVID-19 PCR 11/30  - symptoms of: Shortness of breath and Cough - Vitals: SpO2: 98 % BP 122/67  | Pulse 112  | Temp 36.8 °C (Oral)  | Resp 24  | Wt 122.4 kg  | SpO2 98%  | BMI 49.35 kg/m²  Attending Note: Patient seen and examined with Dr. and I agree with her A/P as above. Patient is a 36 y/o G6P2032 at 21 5/7 wks gest admitted due to worsening SOB with cough in the setting of severe asthma and found to have +Covid, likely exacerbating. S/p Neb treatments in ED prior to diagnosis of Covid with significant improvement in symptoms. Plan to admit for observation and treatment of asthma and Covid as above. Pulmonology and MFM consulted to assist with mgmt. Her pregnancy is also complicated by obesity (BMI 49), Anxiety/depression, cHtn, OSA and HX of 2 prior CS. She has not yet had her anatomy US and was noted to have an abnormal result on her NIPT. Await MFM input and recs for further evaluation while in-patient vs previously scheduled out-patient follow-up with them and Genetics. Reviewed plan of care with patient and all questions answered. CXR normal and no current O2 requirements. note 12/6/21: She is doing well this AM, resting comfortably.  Has her CPAP on and is tolerating this mask well.  She has occasional tightness but it is improved with her inhalers.  Residual cough is mild.  She denies fevers or chills.   She is feeling her baby move and denies any painful contractions, bleeding, or leakage of fluid.
pt devel fever 1 days p/vax & had febrile sz 22hr p/vax;also had emesis, fussiness;adm for r/o sepsis;in hosp for 3 days;
started feeling sluggish late evening of the day of the vaccine shot. Friday, the day after the second shot I had no energy and just felt very ill and remained in bed all day and all night. Felt much better 24 hours later, Saturday morning.
Headache "L side face/ear full-as day progressed it went away. h/a worsened overnight". Narrative:
Patient stated that she was very weak and can not stand for very long at all. Patient had no redness at site, no fever. Recommended patient to go see her Doctor if she gets worse. Patient called back on 11/2/2010 and stated that it took about a week, but now is feeling better.
Swollen thigh, deep red hot rash on thigh, eyes swollen/ drowsy, rash under eyes. No fever.
After receiving my vaccination, I had flu-like symptoms that surpassed the normal 48-hour reaction- I was sick for about 7 days. When this resolved, I suddenly had a full-body rash where any touch or scratch on my skin resulted in itchy, swollen scratch marks/hives (dermatographia). This has continued since.